Miao Xue

机构：Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University · ORCID：0000-0002-2040-6492

发表论文 43 篇 · 总被引 371 次 · h-index 11

代表论文

• Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis (2022 · Cancer Medicine · 被引 17)
• Integrated machine learning screened glutamine metabolism-associated biomarker SLC1A5 to predict immunotherapy response in hepatocellular carcinoma (2024 · Immunobiology · 被引 12)
• A 10-Gene Signature Identified by Machine Learning for Predicting the Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma (2022 · Journal of Oncology · 被引 11)
• Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study (2022 · European Radiology · 被引 10)
• Development and validation of survival prediction models for patients with hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus tyrosine kinase inhibitors (2024 · La radiologia medica · 被引 8)
• Non-Apoptotic Programmed Cell Death-Related Gene Signature Correlates With Stemness and Immune Status and Predicts the Responsiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma (2022 · Frontiers in Cell and Developmental Biology · 被引 7)